Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?
The ophthalmic artificial intelligence-assisted diagnosis market size has experienced rapid expansion recently. It is projected to increase from $2.17 billion in 2025 to $2.57 billion in 2026, driven by a compound annual growth rate (CAGR) of 18.5%. The historical growth of this market can be attributed to the increasing adoption of digital imaging devices, the rising prevalence of eye diseases, enhanced awareness surrounding early diagnosis, the integration of AI in clinical trials, and advancements in retinal imaging technology.
The ophthalmic artificial intelligence-assisted diagnosis market size is anticipated to experience swift expansion in the coming years. It is projected to grow to $5.03 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 18.2%. The anticipated growth within this period can be attributed to the proliferation of cloud-based AI diagnostic platforms, the expansion of tele-ophthalmology services, improved AI algorithms for rare eye disorders, partnerships formed between AI developers and hospitals, and the increased adoption of predictive ophthalmology. Major trends expected during the forecast period include AI-based retinal imaging analysis, deep learning-powered disease detection, predictive ophthalmology models, automated patient record analysis, and the integration of AI with clinical workflows.
Get A Free Sample Report With In-Depth Market Insights:
Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Expansion Drivers: What’s Shaping Future Growth?
The increasing occurrence of eye conditions is anticipated to fuel the expansion of the ophthalmic artificial intelligence-assisted diagnosis market. Eye disorders are health issues or anomalies impacting the eye’s structure or function, potentially leading to impaired vision or ocular health problems. These disorders are becoming more common due to increased screen time from digital device use, leading to digital eye strain, dryness, and long-term vision problems from extended blue light exposure and decreased blinking. Ophthalmic artificial intelligence-assisted diagnosis provides assistance by examining medical images and patient information to identify, categorize, and foresee eye disorders precisely and early, thereby facilitating prompt treatment and lessening the chance of vision loss. For example, in August 2023, the World Health Organization (WHO), a Switzerland-based United Nations agency, reported estimates from 2023 indicating that over 2.2 billion people experience near or distance vision impairment—with more than 1 billion of these cases being preventable or untreated. Refractive errors and cataracts persist as primary causes, yet only 36% of those with refractive error-related impairment and just 17% of those with cataract-related impairment have access to effective interventions. Consequently, the growing prevalence of eye disorders is propelling the development of the ophthalmic artificial intelligence-assisted diagnosis market.
Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Segment Landscape: Which Areas Lead Development?
The ophthalmic artificial intelligence-assisted diagnosis market covered in this report is segmented –
1) By Type: Cloud-Based, On-Premises
2) By Technology: Deep Learning, Machine Learning, Computer Vision, Other Technologies
3) By Application: Hospital, Clinic, Imaging Centre
Subsegments:
1) By Cloud-Based: Public Cloud, Private Cloud, Hybrid Cloud
2) By On-Premises: Local Server Deployment, Enterprise Data Center Deployment, Private Network Deployment
Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Strategic Trends: What Defines The Next Growth Phase?
Leading companies in the ophthalmic artificial intelligence-assisted diagnosis market are concentrating on developing novel solutions, such as an ocular data-as-a-service platform, to improve diagnostic accuracy, optimize patient care, and enable proactive insights for eye conditions. An ocular data-as-a-service platform is a digital offering that delivers eye health data on demand, empowering ophthalmologists, clinics, and AI diagnostic tools to remotely access, share, and analyze retinal images and other ocular information for enhanced diagnosis, monitoring, and research. For instance, in May 2025, Topcon Healthcare Solutions Inc., a US-based digital healthcare solutions company, unveiled IDHea, designed to streamline ophthalmic diagnostics and improve patient outcomes. This cloud-based platform accelerates AI and digital health innovation by providing rapid, secure access to real-world and clinical ocular datasets. It enables researchers to drive advancements in both eye and systemic disease care by transforming clinical data into actionable, AI-powered insights. Founded on the FAST principle, meaning Fast, Accessible, Safe, and Transparent, IDHea facilitates predictive, personalized, and proactive patient care while maintaining stringent privacy and governance standards.
Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Industry Leaders And Competitive Landscape
Major companies operating in the ophthalmic artificial intelligence-assisted diagnosis market are IDx Technologies Inc., Digital Diagnostics Inc., AEYE Health Inc., Eyenuk Inc., OphtAI, Oivi Tech Private Limited, Altris Inc., JuneBrain Inc., Mediwhale Inc., MONA.health BV, Remidio Innovative Solutions Pvt. Ltd., Retinalyze System A/S, Retmarker, RetinaRisk, Ikerian AG, VoxelCloud Inc., Visulytix Ltd., Aiforia Technologies Plc, DeepTek Inc., EyRIS Pte Ltd., Neurodynamics Solutions Inc.
View The Full Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Report:
Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Regional Analysis And Top Geography
North America was the largest region in the ophthalmic artificial intelligence-assisted diagnosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ophthalmic artificial intelligence-assisted diagnosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
